Spyre Therapeutics recently completed a follow-on equity offering, raising approximately US$275 million by issuing about 14.9 million shares of common stock at US$18.50 per share, with the offering ...
Source LinkSpyre Therapeutics recently completed a follow-on equity offering, raising approximately US$275 million by issuing about 14.9 million shares of common stock at US$18.50 per share, with the offering ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.